Description
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs.
Learn more at - https://nfx.com/bio
This is an essay readout using an AI voice clone of NFX general partner, Morgan Beller. Morgan navigates the world of stablecoins and defense tech, emphasizing the need for a synergy between regulators and stablecoin creators. She dives into the historical significance of the dollar's power and...
Published 05/30/24
Hercules builds high-quality, enterprise-grade AI solutions based on data extraction, transformation, and verification, while integrating with enterprise systems and tools for maintenance and monitoring. Join NFX general partner James Currier and HerculesAI CEO Alex Babin talk about the latest...
Published 03/20/24